6547 A phase II study of Docetaxel and Oxaliplatin combination as first-line chemotherapy in recurrent gastric cancer patients after Fluoropyrimidine and/or Cisplatin adjuvant treatment

Gastric Cancer Patients ◽

A phase II study of docetaxel and oxaliplatin combination in recurrent gastric cancer patients after fluoropyrimidine and/or cisplatin adjuvant treatment: a Korean Cancer Study Group Protocol ST06-02

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-012-1956-1 ◽

2012 ◽

Vol 70 (5) ◽

pp. 665-672 ◽

Cited By ~ 4

Author(s):

Yoon Hee Choi ◽

Sang Cheul Oh ◽

Jun Suk Kim ◽

Seung-Hyun Nam ◽

Bong-Seog Kim ◽

...

Keyword(s):

Gastric Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Adjuvant Treatment ◽

Phase Ii Study ◽

Study Group ◽

Cancer Study ◽

Cancer Study Group ◽

Gastric Cancer Patients

P-087 A phase II study of a combination treatment of alternate-day S-1 and lentinan as first-line chemotherapy for unresectable or recurrent gastric cancer

Annals of Oncology ◽

10.1093/annonc/mdw199.84 ◽

2016 ◽

Vol 27 ◽

pp. ii26

Author(s):

S. Yoshino ◽

T. Nishimura ◽

K. Sakata ◽

S. Yoshida ◽

T. Furuya ◽

...

Keyword(s):

Gastric Cancer ◽

Phase Ii ◽

Combination Treatment ◽

Phase Ii Study ◽

First Line ◽

2300 A multicenter randomized phase II study of docetaxel vs. docetaxel plus cisplatin vs. docetaxel plus S-1 as second-line chemotherapy in metastatic gastric cancer patients who had progressed after cisplatin plus either S-1 or capecitabine

European Journal of Cancer ◽

10.1016/s0959-8049(16)31216-3 ◽

2015 ◽

Vol 51 ◽

pp. S432 ◽

Cited By ~ 1

Author(s):

B. Kim ◽

K.W. Lee ◽

M.J. Kim ◽

H.S. Han ◽

Y.L. Park ◽

...

Keyword(s):

Gastric Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Gastric Cancer ◽

Second Line ◽

Second Line Chemotherapy ◽

Randomized Phase Ii ◽

Gastric Cancer Patients ◽

A Randomized Phase II Trial of Biweekly S-1 with Paclitaxel (SPA) or Oxaliplatin (SOX) as First-Line Chemotherapy in advanced Gastric Cancer Patients: Preliminary Results

Annals of Oncology ◽

10.1016/s0923-7534(20)33249-x ◽

2012 ◽

Vol 23 ◽

pp. ix256

Author(s):

M. Haibo ◽

W. Fang ◽

Y. Zheng ◽

P. Zhao ◽

C. Mao ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Trial ◽

First Line ◽

Preliminary Results ◽

Randomized Phase Ii ◽

Gastric Cancer Patients ◽

A Prognostic Model in Metastatic or Recurrent Gastric Cancer Patients with Good Performance Status Who Received First-Line Chemotherapy

Translational Oncology ◽

10.1016/j.tranon.2016.04.004 ◽

2016 ◽

Vol 9 (3) ◽

pp. 256-261 ◽

Cited By ~ 7

Author(s):

Jin Wang ◽

Jinglei Qu ◽

Zhi Li ◽

Xiaofang Che ◽

Jingdong Zhang ◽

...

Keyword(s):

Gastric Cancer ◽

Cancer Patients ◽

Prognostic Model ◽

Performance Status ◽

First Line ◽

Good Performance Status ◽

Gastric Cancer Patients ◽

A Multicenter Randomized Phase II Study of Docetaxel vs. Docetaxel Plus Cisplatin vs. Docetaxel Plus S-1 as Second-Line Chemotherapy in Metastatic Gastric Cancer Patients Who Had Progressed after Cisplatin Plus Either S-1 or Capecitabine

Cancer Research and Treatment ◽

10.4143/crt.2016.216 ◽

2017 ◽

Vol 49 (3) ◽

pp. 706-716 ◽

Cited By ~ 6

Author(s):

Keun-Wook Lee ◽

Bum Jun Kim ◽

Mi-Jung Kim ◽

Hye Sook Han ◽

Jin Won Kim ◽

...

Keyword(s):

Gastric Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Gastric Cancer ◽

Second Line ◽

Second Line Chemotherapy ◽

Randomized Phase Ii ◽

Gastric Cancer Patients ◽

A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients

British Journal of Cancer ◽

10.1038/sj.bjc.6602573 ◽

2005 ◽

Vol 92 (9) ◽

pp. 1644-1649 ◽

Cited By ~ 112

Author(s):

F De Vita ◽

M Orditura ◽

E Matano ◽

R Bianco ◽

C Carlomagno ◽

...

Keyword(s):

Gastric Cancer ◽

Folinic Acid ◽

Advanced Gastric Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

Gastric Cancer Patients ◽

First Line Treatment

Multicenter phase II study of S-1 and docetaxel combination chemotherapy for advanced or recurrent gastric cancer patients with peritoneal dissemination

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-013-2086-0 ◽

2013 ◽

Vol 71 (4) ◽

pp. 937-943 ◽

Cited By ~ 5

Author(s):

Kunitoshi Shigeyasu ◽

Shunsuke Kagawa ◽

Futoshi Uno ◽

Masahiko Nishizaki ◽

Hiroyuki Kishimoto ◽

...

Keyword(s):

Gastric Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Combination Chemotherapy ◽

Peritoneal Dissemination ◽

Phase Ii Study ◽

Multicenter Phase ◽

Gastric Cancer Patients

A Retrospective Study of the Safety and Efficacy of a First-Line Treatment with Modified FOLFOX-4 in Unresectable Advanced or Recurrent Gastric Cancer Patients

Chemotherapy ◽

10.1159/000345742 ◽

2012 ◽

Vol 58 (5) ◽

pp. 411-418 ◽

Cited By ~ 8

Author(s):

Yung-Sung Yeh ◽

Hsiang-Lin Tsai ◽

Cheng-Jen Ma ◽

Deng-Chyang Wu ◽

Chien-Yu Lu ◽

...

Keyword(s):

Gastric Cancer ◽

Retrospective Study ◽

Cancer Patients ◽

Line Treatment ◽

First Line ◽

Safety And Efficacy ◽

Gastric Cancer Patients ◽

First Line Treatment

Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy

Journal of Translational Medicine ◽

10.1186/s12967-018-1385-y ◽

2018 ◽

Vol 16 (1) ◽

Cited By ~ 6

Author(s):

Elisa Melucci ◽

Beatrice Casini ◽

Livia Ronchetti ◽

Laura Pizzuti ◽

Francesca Sperati ◽

...

Keyword(s):

Gastric Cancer ◽

Advanced Gastric Cancer ◽

Cancer Patients ◽

Wnt Pathway ◽

Survival Outcomes ◽

First Line ◽

Gastric Cancer Patients ◽